| 1 |
Ding Y, Yi J, Wang J, Sun Z. Interleukin-1 receptor antagonist: a promising cytokine against human squamous cell carcinomas. Heliyon 2023. [DOI: 10.1016/j.heliyon.2023.e14960] [Reference Citation Analysis]
|
| 2 |
Garbin LC, McIlwraith CW, Frisbie DD. Use of allogeneic freeze-dried conditioned serum for the prevention of degradation in cartilage exposed to IL-1ß. BMC Vet Res 2022;18:265. [PMID: 35820849 DOI: 10.1186/s12917-022-03227-2] [Reference Citation Analysis]
|
| 3 |
Tamura Y, Yamato M, Kataoka Y. Animal Models for Neuroinflammation and Potential Treatment Methods. Front Neurol 2022;13:890217. [DOI: 10.3389/fneur.2022.890217] [Reference Citation Analysis]
|
| 4 |
Pfeifer J, Thurner B, Kessel C, Fadle N, Kheiroddin P, Regitz E, Hoffmann M, Kos IA, Preuss K, Fischer Y, Roemer K, Lohse S, Heyne K, Detemple M, Fedlmeier M, Juenger H, Sauer H, Meyer S, Rohrer T, Wittkowski H, Becker SL, Masjosthusmann K, Bals R, Gerling S, Smola S, Bewarder M, Birk E, Keren A, Böhm M, Jakob A, Abdul-khaliq H, Anton J, Kabesch M, Pino-ramirez RM, Foell D, Thurner L. Autoantibodies against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort study. The Lancet Rheumatology 2022;4:e329-37. [DOI: 10.1016/s2665-9913(22)00064-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 5 |
Garbin LC, Contino EK, Olver CS, Frisbie DD. A safety evaluation of allogeneic freeze-dried platelet-rich plasma or conditioned serum compared to autologous frozen products equivalents in equine healthy joints. BMC Vet Res 2022;18:141. [PMID: 35436878 DOI: 10.1186/s12917-022-03225-4] [Reference Citation Analysis]
|
| 6 |
Ngcobo S, Molatlhegi RP, Osman F, Ngcapu S, Samsunder N, Garrett NJ, Abdool Karim SS, Abdool Karim Q, Mckinnon LR, Sivro A. Pre-infection plasma cytokines and chemokines as predictors of HIV disease progression. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-06532-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 7 |
Mennink LM, Aalbers MW, van Dijk P, van Dijk JMC. The Role of Inflammation in Tinnitus: A Systematic Review and Meta-Analysis. J Clin Med 2022;11:1000. [PMID: 35207270 DOI: 10.3390/jcm11041000] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 8 |
Niklander SE, Murdoch C, Hunter KD. IL-1/IL-1R Signaling in Head and Neck Cancer. Front Oral Health 2021;2:722676. [PMID: 35048046 DOI: 10.3389/froh.2021.722676] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 9 |
de Castro JC. Regenerative Medicine Procedures Under Ultrasound Guidance. Musculoskeletal Ultrasound-Guided Regenerative Medicine 2022. [DOI: 10.1007/978-3-030-98256-0_14] [Reference Citation Analysis]
|
| 10 |
Hoste E, Lecomte K, Annusver K, Vandamme N, Roels J, Maschalidi S, Verboom L, Vikkula HK, Sze M, Van Hove L, Verstaen K, Martens A, Hochepied T, Saeys Y, Ravichandran K, Kasper M, van Loo G. OTULIN maintains skin homeostasis by controlling keratinocyte death and stem cell identity. Nat Commun 2021;12:5913. [PMID: 34625556 DOI: 10.1038/s41467-021-25944-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 11 |
Woodell-May J, Steckbeck K, King W. Potential Mechanism of Action of Current Point-of-Care Autologous Therapy Treatments for Osteoarthritis of the Knee-A Narrative Review. Int J Mol Sci 2021;22:2726. [PMID: 33800401 DOI: 10.3390/ijms22052726] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 12 |
Camargo Garbin L, Morris MJ. A Comparative Review of Autologous Conditioned Serum and Autologous Protein Solution for Treatment of Osteoarthritis in Horses. Front Vet Sci 2021;8:602978. [PMID: 33681323 DOI: 10.3389/fvets.2021.602978] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 13 |
Kasper M, Heming M, Schafflick D, Li X, Lautwein T, zu Horste MM, Bauer D, Walscheid K, Wiendl H, Loser K, Heiligenhaus A, zu Horste GM. Intra-ocular dendritic cells are increased in HLA-B27 associated acute anterior uveitis.. [DOI: 10.1101/2021.02.16.431370] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 14 |
Harm S, Schildböck C, Strobl K, Hartmann J. An in vitro study on factors affecting endotoxin neutralization in human plasma using the Limulus amebocyte lysate test. Sci Rep 2021;11:4192. [PMID: 33603020 DOI: 10.1038/s41598-021-83487-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 15 |
ElTanbouly MA, Zhao Y, Schaafsma E, Burns CM, Mabaera R, Cheng C, Noelle RJ. VISTA: A Target to Manage the Innate Cytokine Storm. Front Immunol 2020;11:595950. [PMID: 33643285 DOI: 10.3389/fimmu.2020.595950] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 16 |
Li J, Bao G, Wang H. Time to Develop Therapeutic Antibodies Against Harmless Proteins Colluding with Sepsis Mediators? Immunotargets Ther 2020;9:157-66. [PMID: 33117741 DOI: 10.2147/ITT.S262605] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 17 |
Soriano A, Soriano M, Espinosa G, Manna R, Emmi G, Cantarini L, Hernández-Rodríguez J. Current Therapeutic Options for the Main Monogenic Autoinflammatory Diseases and PFAPA Syndrome: Evidence-Based Approach and Proposal of a Practical Guide. Front Immunol 2020;11:865. [PMID: 32655539 DOI: 10.3389/fimmu.2020.00865] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 10.7] [Reference Citation Analysis]
|
| 18 |
Koehn BH, Saha A, McDonald-Hyman C, Loschi M, Thangavelu G, Ma L, Zaiken M, Dysthe J, Krepps W, Panthera J, Hippen K, Jameson SC, Miller JS, Cooper MA, Farady CJ, Iwawaki T, Ting JP, Serody JS, Murphy WJ, Hill GR, Murray PJ, Bronte V, Munn DH, Zeiser R, Blazar BR. Danger-associated extracellular ATP counters MDSC therapeutic efficacy in acute GVHD. Blood 2019;134:1670-82. [PMID: 31533918 DOI: 10.1182/blood.2019001950] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 11.3] [Reference Citation Analysis]
|
| 19 |
Kaneko N, Kurata M, Yamamoto T, Morikawa S, Masumoto J. The role of interleukin-1 in general pathology. Inflamm Regen 2019;39:12. [PMID: 31182982 DOI: 10.1186/s41232-019-0101-5] [Cited by in Crossref: 137] [Cited by in F6Publishing: 149] [Article Influence: 34.3] [Reference Citation Analysis]
|
| 20 |
Barnes J. Biologic Agents to Control Autoimmune Inflammation. Translational Inflammation 2019. [DOI: 10.1016/b978-0-12-813832-8.00009-1] [Reference Citation Analysis]
|
| 21 |
Van Belleghem JD, Dąbrowska K, Vaneechoutte M, Barr JJ. Phage Interaction with the Mammalian Immune System. Phage Therapy: A Practical Approach 2019. [DOI: 10.1007/978-3-030-26736-0_4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 22 |
Cassano JM, Kennedy JG, Ross KA, Fraser EJ, Goodale MB, Fortier LA. Bone marrow concentrate and platelet-rich plasma differ in cell distribution and interleukin 1 receptor antagonist protein concentration. Knee Surg Sports Traumatol Arthrosc 2018;26:333-42. [PMID: 26831858 DOI: 10.1007/s00167-016-3981-9] [Cited by in Crossref: 124] [Cited by in F6Publishing: 201] [Article Influence: 24.8] [Reference Citation Analysis]
|
| 23 |
Yu M, Tsai SF, Kuo YM. The Therapeutic Potential of Anti-Inflammatory Exerkines in the Treatment of Atherosclerosis. Int J Mol Sci 2017;18:E1260. [PMID: 28608819 DOI: 10.3390/ijms18061260] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.7] [Reference Citation Analysis]
|
| 24 |
Arbel R. Orthokine. Bio-orthopaedics 2017. [DOI: 10.1007/978-3-662-54181-4_45] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 25 |
Kang R, Zeng L, Xie Y, Yan Z, Zhou B, Cao L, Klionsky DJ, Tracey KJ, Li J, Wang H, Billiar TR, Jiang J, Tang D. A novel PINK1- and PARK2-dependent protective neuroimmune pathway in lethal sepsis. Autophagy 2016;12:2374-85. [PMID: 27754761 DOI: 10.1080/15548627.2016.1239678] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 8.1] [Reference Citation Analysis]
|
| 26 |
Sosvorova L, Mohapl M, Vcelak J, Hill M, Vitku J, Hampl R. The impact of selected cytokines in the follow-up of normal pressure hydrocephalus. Physiol Res 2015;64:S283-90. [PMID: 26680491 DOI: 10.33549/physiolres.933069] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 27 |
Rütten S, Schusser GF, Abraham G, Schrödl W. Release kinetics of tumor necrosis factor-α and interleukin-1 receptor antagonist in the equine whole blood. BMC Vet Res 2016;12:117. [PMID: 27316332 DOI: 10.1186/s12917-016-0742-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 28 |
Ortved KF, Austin BS, Scimeca MS, Nixon AJ. RNA Interference Mediated Interleukin-1β Silencing in Inflamed Chondrocytes Decreases Target and Downstream Catabolic Responses. Arthritis 2016;2016:3484961. [PMID: 27073697 DOI: 10.1155/2016/3484961] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 29 |
Zhang Z, Deng W, Kang R, Xie M, Billiar T, Wang H, Cao L, Tang D. Plumbagin Protects Mice from Lethal Sepsis by Modulating Immunometabolism Upstream of PKM2. Mol Med 2016;22:162-72. [PMID: 26982513 DOI: 10.2119/molmed.2015.00250] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 30 |
Bashir H, Ahmed N, Khan MA, Zafar AU, Tahir S, Kanwal H, Khan F, Rahman ZU, Husnain T. Evaluating the autoinduction expression system and one-step purification for high-level expression and purification of gallbladder-derived rhIL-1Ra. Biotechnol Appl Biochem 2017;64:20-6. [PMID: 26620912 DOI: 10.1002/bab.1463] [Reference Citation Analysis]
|
| 31 |
Yuan J, Wang L, Lin Y, Chen J, Hu J. Differences of plasma IL-1 and TNF-α in healthy Chinese Population. Open Med (Wars) 2015;10:306-10. [PMID: 28352710 DOI: 10.1515/med-2015-0044] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 32 |
Gurung P, Kanneganti TD. Novel roles for caspase-8 in IL-1β and inflammasome regulation. Am J Pathol 2015;185:17-25. [PMID: 25451151 DOI: 10.1016/j.ajpath.2014.08.025] [Cited by in Crossref: 115] [Cited by in F6Publishing: 104] [Article Influence: 12.8] [Reference Citation Analysis]
|
| 33 |
Johnson E, Yassin W, Guignet M. Inflammatory Biomarkers of Brain Injury and Disease. Biomarkers of Brain Injury and Neurological Disorders 2014. [DOI: 10.1201/b17644-13] [Reference Citation Analysis]
|
| 34 |
Jeong JY, Lee YJ, Han JH, Park SY, Hwang KW, Sohn UD. The inhibitory effect of PIK-75 on inflammatory mediator response induced by hydrogen peroxide in feline esophageal epithelial cells. Mediators Inflamm 2014;2014:178049. [PMID: 25276052 DOI: 10.1155/2014/178049] [Reference Citation Analysis]
|
| 35 |
Saniabadi AR, Tanaka T, Ohmori T, Sawada K, Yamamoto T, Hanai H. Treating inflammatory bowel disease by adsorptive leucocytapheresis: A desire to treat without drugs. World J Gastroenterol 2014; 20(29): 9699-9715 [PMID: 25110409 DOI: 10.3748/wjg.v20.i29.9699] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 57] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 36 |
Yang L, Xie M, Yang M, Yu Y, Zhu S, Hou W, Kang R, Lotze MT, Billiar TR, Wang H, Cao L, Tang D. PKM2 regulates the Warburg effect and promotes HMGB1 release in sepsis. Nat Commun 2014;5:4436. [PMID: 25019241 DOI: 10.1038/ncomms5436] [Cited by in Crossref: 247] [Cited by in F6Publishing: 263] [Article Influence: 27.4] [Reference Citation Analysis]
|
| 37 |
Martin F, Sewer A, Talikka M, Xiang Y, Hoeng J, Peitsch MC. Quantification of biological network perturbations for mechanistic insight and diagnostics using two-layer causal models. BMC Bioinformatics 2014;15:238. [PMID: 25015298 DOI: 10.1186/1471-2105-15-238] [Cited by in Crossref: 90] [Cited by in F6Publishing: 92] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 38 |
Lin J, Chang YJ, Yang WB, Yu AL, Wong CH. The multifaceted effects of polysaccharides isolated from Dendrobium huoshanense on immune functions with the induction of interleukin-1 receptor antagonist (IL-1ra) in monocytes. PLoS One 2014;9:e94040. [PMID: 24705413 DOI: 10.1371/journal.pone.0094040] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 39 |
Yamato M, Tamura Y, Eguchi A, Kume S, Miyashige Y, Nakano M, Watanabe Y, Kataoka Y. Brain interleukin-1β and the intrinsic receptor antagonist control peripheral Toll-like receptor 3-mediated suppression of spontaneous activity in rats. PLoS One 2014;9:e90950. [PMID: 24621600 DOI: 10.1371/journal.pone.0090950] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 40 |
Prins M, Eriksson C, Wierinckx A, Bol JG, Binnekade R, Tilders FJ, Van Dam AM. Interleukin-1β and interleukin-1 receptor antagonist appear in grey matter additionally to white matter lesions during experimental multiple sclerosis. PLoS One 2013;8:e83835. [PMID: 24376764 DOI: 10.1371/journal.pone.0083835] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 41 |
Park EJ, Jang HJ, Tsoyi K, Kim YM, Park SW, Kim HJ, Lee JH, Chang KC. The heme oxygenase-1 inducer THI-56 negatively regulates iNOS expression and HMGB1 release in LPS-activated RAW 264.7 cells and CLP-induced septic mice. PLoS One 2013;8:e76293. [PMID: 24098466 DOI: 10.1371/journal.pone.0076293] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 42 |
Goodrich LR, Phillips JN, McIlwraith CW, Foti SB, Grieger JC, Gray SJ, Samulski RJ. Optimization of scAAVIL-1ra In Vitro and In Vivo to Deliver High Levels of Therapeutic Protein for Treatment of Osteoarthritis. Mol Ther Nucleic Acids 2013;2:e70. [PMID: 23385523 DOI: 10.1038/mtna.2012.61] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 43 |
Wang H, Zhu S, Li W, Jundoria A, Sama AE. Tea and Sepsis. Tea in Health and Disease Prevention 2013. [DOI: 10.1016/b978-0-12-384937-3.00048-3] [Reference Citation Analysis]
|
| 44 |
Scheer JM. Caspase-1. Handbook of Proteolytic Enzymes 2013. [DOI: 10.1016/b978-0-12-382219-2.00503-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 45 |
Issekutz AC, Lopes N, Issekutz TB. Role of interleukin-1 and tumour necrosis factor in leukocyte recruitment to acute dermal inflammation. Mediators Inflamm 1992;1:347-53. [PMID: 18475483 DOI: 10.1155/S0962935192000528] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 46 |
Lue LF, Andrade C, Sabbagh M, Walker D. Is There Inflammatory Synergy in Type II Diabetes Mellitus and Alzheimer's Disease? Int J Alzheimers Dis 2012;2012:918680. [PMID: 22779027 DOI: 10.1155/2012/918680] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 47 |
Song JK, Park MH, Choi DY, Yoo HS, Han SB, Yoon DY, Hong JT. Deficiency of C-C chemokine receptor 5 suppresses tumor development via inactivation of NF-κB and upregulation of IL-1Ra in melanoma model. PLoS One 2012;7:e33747. [PMID: 22567084 DOI: 10.1371/journal.pone.0033747] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 48 |
Wang H, Sama AE, Ward MF, Miele KL, Zhu S. Future Application of Integrative Therapies for Sepsis: Bench and Experimental Animal Models. Integrative Therapies in Lung Health and Sleep 2012. [DOI: 10.1007/978-1-61779-579-4_11] [Reference Citation Analysis]
|
| 49 |
Ablamunits V, Henegariu O, Hansen JB, Opare-Addo L, Preston-Hurlburt P, Santamaria P, Mandrup-Poulsen T, Herold KC. Synergistic reversal of type 1 diabetes in NOD mice with anti-CD3 and interleukin-1 blockade: evidence of improved immune regulation. Diabetes 2012;61:145-54. [PMID: 22043003 DOI: 10.2337/db11-1033] [Cited by in Crossref: 84] [Cited by in F6Publishing: 89] [Article Influence: 7.6] [Reference Citation Analysis]
|
| 50 |
Pandey GN, Rizavi HS, Ren X, Fareed J, Hoppensteadt DA, Roberts RC, Conley RR, Dwivedi Y. Proinflammatory cytokines in the prefrontal cortex of teenage suicide victims. J Psychiatr Res 2012;46:57-63. [PMID: 21906753 DOI: 10.1016/j.jpsychires.2011.08.006] [Cited by in Crossref: 236] [Cited by in F6Publishing: 265] [Article Influence: 21.5] [Reference Citation Analysis]
|
| 51 |
Mayado A, Torres E, Gutierrez-Lopez MD, Colado MI, O'Shea E. Increased interleukin-1β levels following low dose MDMA induces tolerance against the 5-HT neurotoxicity produced by challenge MDMA. J Neuroinflammation 2011;8:165. [PMID: 22114930 DOI: 10.1186/1742-2094-8-165] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 52 |
Manca C, Peixoto B, Malaga W, Guilhot C, Kaplan G. Modulation of the cytokine response in human monocytes by mycobacterium leprae phenolic glycolipid-1. J Interferon Cytokine Res 2012;32:27-33. [PMID: 21981546 DOI: 10.1089/jir.2011.0044] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 53 |
Zhu S, Li W, Ward MF, Sama AE, Wang H. High mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation. Inflamm Allergy Drug Targets 2010;9:60-72. [PMID: 19906009 DOI: 10.2174/187152810791292872] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 54 |
Cai B, Deitch EA, Ulloa L. Novel insights for systemic inflammation in sepsis and hemorrhage. Mediators Inflamm 2010;2010:642462. [PMID: 20628562 DOI: 10.1155/2010/642462] [Cited by in Crossref: 67] [Cited by in F6Publishing: 78] [Article Influence: 5.2] [Reference Citation Analysis]
|
| 55 |
Rieder F, Biancani P, Harnett K, Yerian L, Falk GW. Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis. Am J Physiol Gastrointest Liver Physiol 2010;298:G571-81. [PMID: 20299604 DOI: 10.1152/ajpgi.00454.2009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 56 |
Rieder F, Biancani P, Harnett K, Yerian L, Falk GW. Inflammatory mediators in gastroesophageal reflux disease: impact on esophageal motility, fibrosis, and carcinogenesis. Am J Physiol Gastrointest Liver Physiol 2010;298:G571-81. [PMID: 20299604 DOI: 10.1152/ajpgi.00454.2009] [Cited by in Crossref: 73] [Cited by in F6Publishing: 81] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 57 |
Wang H, Ward MF, Sama AE. Novel HMGB1-inhibiting therapeutic agents for experimental sepsis. Shock. 2009;32:348-357. [PMID: 19333143 DOI: 10.1097/SHK.0b013e3181a551bd] [Cited by in Crossref: 92] [Cited by in F6Publishing: 103] [Article Influence: 7.1] [Reference Citation Analysis]
|
| 58 |
Zhu S, Ashok M, Li J, Li W, Yang H, Wang P, Tracey KJ, Sama AE, Wang H. Spermine protects mice against lethal sepsis partly by attenuating surrogate inflammatory markers. Mol Med 2009;15:275-82. [PMID: 19593412 DOI: 10.2119/molmed.2009.00062] [Cited by in Crossref: 64] [Cited by in F6Publishing: 73] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 59 |
Wang H, Zhu S, Zhou R, Li W, Sama AE. Therapeutic potential of HMGB1-targeting agents in sepsis. Expert Rev Mol Med 2008;10:e32. [PMID: 18980707 DOI: 10.1017/S1462399408000884] [Cited by in Crossref: 79] [Cited by in F6Publishing: 92] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 60 |
Mahdaviani SA, Rezaei N, Moradi B, Dorkhosh S, Amirzargar AA, Movahedi M. Proinflammatory cytokine gene polymorphisms among Iranian patients with asthma. J Clin Immunol 2009;29:57-62. [PMID: 18763028 DOI: 10.1007/s10875-008-9232-1] [Cited by in Crossref: 40] [Cited by in F6Publishing: 47] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 61 |
Schreuder HA, Rondeau JM, Tardif C, Soffientini A, Sarubbi E, Akeson A, Bowlin TL, Yanofsky S, Barrett RW. Refined Crystal Structure of the Interleukin-1 Receptor Antagonist. European Journal of Biochemistry 2008;227:838-847. [DOI: 10.1111/j.1432-1033.1995.0838p.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 62 |
Invernizzi P, Bianchi I, Locati M, Bonecchi R, Selmi C. Cytokines in Liver Health and Disease. Liver Immunology. [DOI: 10.1007/978-1-59745-518-3_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 63 |
Samuel EA, Burrows A, Kerschner JE. Cytokine regulation of mucin secretion in a human middle ear epithelial model. Cytokine 2008;41:38-43. [PMID: 18063379 DOI: 10.1016/j.cyto.2007.10.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 64 |
Li W, Ashok M, Li J, Yang H, Sama AE, Wang H. A major ingredient of green tea rescues mice from lethal sepsis partly by inhibiting HMGB1. PLoS One 2007;2:e1153. [PMID: 17987129 DOI: 10.1371/journal.pone.0001153] [Cited by in Crossref: 99] [Cited by in F6Publishing: 107] [Article Influence: 6.2] [Reference Citation Analysis]
|
| 65 |
Kleinschnitz C, Meuth SG, Kieseier BC, Wiendl H. [Update on pathophysiologic and immunotherapeutic approaches for the treatment of multiple sclerosis]. Nervenarzt 2007;78:883-911. [PMID: 17551708 DOI: 10.1007/s00115-007-2261-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 66 |
Li W, Li J, Ashok M, Wu R, Chen D, Yang L, Yang H, Tracey KJ, Wang P, Sama AE, Wang H. A cardiovascular drug rescues mice from lethal sepsis by selectively attenuating a late-acting proinflammatory mediator, high mobility group box 1. J Immunol 2007;178:3856-64. [PMID: 17339485 DOI: 10.4049/jimmunol.178.6.3856] [Cited by in Crossref: 104] [Cited by in F6Publishing: 111] [Article Influence: 6.5] [Reference Citation Analysis]
|
| 67 |
Cominelli F, Arseneau KO, Pizarro TT. The mucosal inflammatory response. Cytokines and chemokines. Inflammatory Bowel Disease: From Bench to Bedside. [DOI: 10.1007/0-387-25808-6_7] [Reference Citation Analysis]
|
| 68 |
Mitsuyama K, Tomiyasu N, Takaki K, Masuda J, Yamasaki H, Kuwaki K, Takeda T, Kitazaki S, Tsuruta O, Sata M. Interleukin-10 in the pathophysiology of inflammatory bowel disease: increased serum concentrations during the recovery phase. Mediators Inflamm. 2006;2006:26875. [PMID: 17392581 DOI: 10.1155/mi/2006/26875] [Cited by in Crossref: 29] [Cited by in F6Publishing: 37] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 69 |
Moser C, Ilg A, Wehling P. Zytokinantagonisten in der Behandlung der Gonarthrose. Knie 2007. [DOI: 10.1007/978-3-7985-1588-8_3] [Reference Citation Analysis]
|
| 70 |
Hanai H. Positions of selective leukocytapheresis in the medical therapy of ulcerative colitis. World J Gastroenterol 2006; 12(47): 7568-7577 [PMID: 17171783 DOI: 10.3748/wjg.v12.i47.7568] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 38] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 71 |
Shinoda M, Tilles AW, Kobayashi N, Wakabayashi G, Takayanagi A, Totsugawa T, Harada H, Obara H, Suganuma K, Berthiaume F. A bioartificial liver device secreting interleukin-1 receptor antagonist for the treatment of hepatic failure in rats. J Surg Res. 2007;137:130-140. [PMID: 17081566 DOI: 10.1016/j.jss.2006.08.009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 72 |
Wang H, Li W, Li J, Rendon-Mitchell B, Ochani M, Ashok M, Yang L, Yang H, Tracey KJ, Wang P, Sama AE. The aqueous extract of a popular herbal nutrient supplement, Angelica sinensis, protects mice against lethal endotoxemia and sepsis. J Nutr 2006;136:360-5. [PMID: 16424112 DOI: 10.1093/jn/136.2.360] [Cited by in Crossref: 66] [Cited by in F6Publishing: 71] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 73 |
Chen X, Li W, Wang H. More tea for septic patients?--Green tea may reduce endotoxin-induced release of high mobility group box 1 and other pro-inflammatory cytokines. Med Hypotheses 2006;66:660-3. [PMID: 16266789 DOI: 10.1016/j.mehy.2005.09.025] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 74 |
Wiendl H, Hohlfeld R. Cytokine-Based Therapeutics for Intrinsic CNS Disease Processes. Cytokines and the CNS 2005. [DOI: 10.1201/9781420039849.ch14] [Reference Citation Analysis]
|
| 75 |
Sama AE, D'amore J, Ward MF, Chen G, Wang H. Bench to Bedside: HMGB1—A Novel Proinflammatory Cytokine and Potential Therapeutic Target for Septic Patients in the Emergency Department. Acad Emergency Med 2004;11:867-73. [DOI: 10.1111/j.1553-2712.2004.tb00770.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 76 |
Lee JK, Kim SH, Lewis EC, Azam T, Reznikov LL, Dinarello CA. Differences in signaling pathways by IL-1beta and IL-18. Proc Natl Acad Sci U S A 2004;101:8815-20. [PMID: 15161979 DOI: 10.1073/pnas.0402800101] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 77 |
Lee JK, Kim SH, Lewis EC, Azam T, Reznikov LL, Dinarello CA. Differences in signaling pathways by IL-1beta and IL-18. Proc Natl Acad Sci U S A 2004;101:8815-20. [PMID: 15161979 DOI: 10.1073/pnas.0402800101] [Cited by in Crossref: 175] [Cited by in F6Publishing: 183] [Article Influence: 9.2] [Reference Citation Analysis]
|
| 78 |
Smith YR, Haefner HK. Vulvar lichen sclerosus : pathophysiology and treatment. Am J Clin Dermatol 2004;5:105-25. [PMID: 15109275 DOI: 10.2165/00128071-200405020-00005] [Cited by in Crossref: 109] [Cited by in F6Publishing: 486] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 79 |
Hoffmann U, Fischereder M, Marx M, Schweda F, Lang B, Straub RH, Krämer BK. Induction of cytokines and adhesion molecules in stable hemodialysis patients: is there an effect of membrane material? Am J Nephrol 2003;23:442-7. [PMID: 14583663 DOI: 10.1159/000074536] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 80 |
Mulcahy NJ, Ross J, Rothwell NJ, Loddick SA. Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischaemia in the rat. Br J Pharmacol 2003;140:471-6. [PMID: 12970087 DOI: 10.1038/sj.bjp.0705462] [Cited by in Crossref: 133] [Cited by in F6Publishing: 150] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 81 |
Molina-Holgado F, Pinteaux E, Moore JD, Molina-Holgado E, Guaza C, Gibson RM, Rothwell NJ. Endogenous interleukin-1 receptor antagonist mediates anti-inflammatory and neuroprotective actions of cannabinoids in neurons and glia. J Neurosci 2003;23:6470-4. [PMID: 12878687 [PMID: 12878687 DOI: 10.1523/jneurosci.23-16-06470.2003] [Cited by in Crossref: 152] [Cited by in F6Publishing: 152] [Article Influence: 7.6] [Reference Citation Analysis]
|
| 82 |
Tarkowski E, Andreasen N, Tarkowski A, Blennow K. Intrathecal inflammation precedes development of Alzheimer's disease. J Neurol Neurosurg Psychiatry 2003;74:1200-5. [PMID: 12933918 DOI: 10.1136/jnnp.74.9.1200] [Cited by in Crossref: 301] [Cited by in F6Publishing: 321] [Article Influence: 15.1] [Reference Citation Analysis]
|
| 83 |
Niizeki H, Yokoyama M, Inamoto N, Nishikawa T, Naruse T, Inoko H, Hashigucci K. Lack of association of the interleukin-1 receptor antagonist gene with palmoplantar pustulosis in Japanese. Eur J Immunogenet 2003;30:249-52. [PMID: 12919285 DOI: 10.1046/j.1365-2370.2003.00403.x] [Reference Citation Analysis]
|
| 84 |
Kerschner JE, Meyer TK, Wohlfeill E. Middle ear epithelial mucin production in response to interleukin 1β exposure in vitro. Otolaryngol Head Neck Surg 2003;129:128-135. [DOI: 10.1016/s0194-59980300532-1] [Reference Citation Analysis]
|
| 85 |
Wilkinson N, Jackson G, Gardner-Medwin J. Biologic therapies for juvenile arthritis. Arch Dis Child 2003;88:186-91. [PMID: 12598373 DOI: 10.1136/adc.88.3.186] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 86 |
Cominelli F, Arseneau KO, Pizarro TT. The mucosal inflammatory response. Cytokines and chemokines. Inflammatory Bowel Disease: From Bench to Bedside 2003. [DOI: 10.1007/978-1-4020-3477-0_7] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 87 |
van der Meer JWM, Kullberg BJ. Defects in Host Defense Mechanisms. Clinical Approach to Infection in the Compromised Host 2002. [DOI: 10.1007/0-306-47527-8_2] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 88 |
Wehling P. Transfert de gènes aux cellules du disque intervertébral : proposition d’une stratégie de thérapie génique appliquée à la pathologie rachidienne. Revue du Rhumatisme 2001;68:920-922. [DOI: 10.1016/s1169-8330(01)00214-9] [Reference Citation Analysis]
|
| 89 |
Piguet PF, Kan CD, Vesin C, Rochat A, Donati Y, Barazzone C. Role of CD40-CVD40L in mouse severe malaria. Am J Pathol 2001;159:733-42. [PMID: 11485931 DOI: 10.1016/s0002-9440(10)61744-0] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 90 |
Rodríguez-Ramos C, Galan F, Díaz F, Elvira J, Martín-Herrera L, Girón-González JA. Expression of proinflammatory cytokines and their inhibitors during the course of spontaneous bacterial peritonitis. Dig Dis Sci 2001;46:1668-76. [PMID: 11508666 DOI: 10.1023/a:1010645302750] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 91 |
Wang N, Chintala SK, Fini ME, Schuman JS. Activation of a tissue-specific stress response in the aqueous outflow pathway of the eye defines the glaucoma disease phenotype. Nat Med 2001;7:304-9. [PMID: 11231628 DOI: 10.1038/85446] [Cited by in Crossref: 138] [Cited by in F6Publishing: 172] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 92 |
Cartmell T, Luheshi GN, Hopkins SJ, Rothwell NJ, Poole S. Role of endogenous interleukin-1 receptor antagonist in regulating fever induced by localised inflammation in the rat. J Physiol 2001;531:171-80. [PMID: 11179401 DOI: 10.1111/j.1469-7793.2001.0171j.x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 93 |
Hori T, Kaizuka Y, Takaki A, Katafuchi T. Thermal Stress and Immunity. Thermotherapy for Neoplasia, Inflammation, and Pain 2001. [DOI: 10.1007/978-4-431-67035-3_27] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 94 |
Conti F, Breton S, Batteux F, Furlan V, Houssin D, Weill B, Calmus Y. Defective interleukin-1 receptor antagonist production is associated with resistance of acute liver graft rejection to steroid therapy. Am J Pathol 2000;157:1685-92. [PMID: 11073827 DOI: 10.1016/S0002-9440(10)64805-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 95 |
von Baehr V, Döcke WD, Plauth M, Liebenthal C, Küpferling S, Lochs H, Baumgarten R, Volk HD. Mechanisms of endotoxin tolerance in patients with alcoholic liver cirrhosis: role of interleukin 10, interleukin 1 receptor antagonist, and soluble tumour necrosis factor receptors as well as effector cell desensitisation. Gut 2000;47:281-7. [PMID: 10896923 DOI: 10.1136/gut.47.2.281] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 96 |
Cunha JM, Cunha FQ, Poole S, Ferreira SH. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist. Br J Pharmacol 2000;130:1418-24. [PMID: 10903985 DOI: 10.1038/sj.bjp.0703434] [Cited by in Crossref: 152] [Cited by in F6Publishing: 154] [Article Influence: 6.6] [Reference Citation Analysis]
|
| 97 |
Levine AD, Fiocchi C. Cytokines. Drug Development 2000. [DOI: 10.1007/978-1-59259-202-9_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 98 |
Sumitomo M, Tachibana M, Murai M, Hayakawa M, Nakamura H, Takayanagi A, Shimizu N. Overexpression of IL-1ra gene up-regulates interleukin-1beta converting enzyme (ICE) gene expression: possible mechanism underlying IL-1beta-resistance of cancer cells. Br J Cancer 1999;81:277-86. [PMID: 10496353 DOI: 10.1038/sj.bjc.6690688] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 99 |
Murthy S, Cooper HS, Yoshitake H, Meyer C, Meyer CJ, Murthy NS. Combination therapy of pentoxifylline and TNFalpha monoclonal antibody in dextran sulphate-induced mouse colitis. Aliment Pharmacol Ther 1999;13:251-60. [PMID: 10102957 DOI: 10.1046/j.1365-2036.1999.00457.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 61] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 100 |
Rothwell NJ. Annual review prize lecture cytokines - killers in the brain? J Physiol 1999;514 ( Pt 1):3-17. [PMID: 9831712 DOI: 10.1111/j.1469-7793.1999.003af.x] [Cited by in Crossref: 178] [Cited by in F6Publishing: 190] [Article Influence: 7.4] [Reference Citation Analysis]
|
| 101 |
Aukrust P, Müller F, Svenson M, Nordøy I, Bendtzen K, Frøland SS. Administration of intravenous immunoglobulin (IVIG) in vivo--down-regulatory effects on the IL-1 system. Clin Exp Immunol 1999;115:136-43. [PMID: 9933433 DOI: 10.1046/j.1365-2249.1999.00757.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 43] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 102 |
Rocha MF, Soares AM, Flores CA, Steiner TS, Lyerly DM, Guerrant RL, Ribeiro RA, Lima AA. Intestinal secretory factor released by macrophages stimulated with Clostridium difficile toxin A: role of interleukin 1beta. Infect Immun 1998;66:4910-6. [PMID: 9746596 DOI: 10.1128/IAI.66.10.4910-4916.1998] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 103 |
Liu JSH, Amaral TD, Brosnan CF, Lee SC. IFNs Are Critical Regulators of IL-1 Receptor Antagonist and IL-1 Expression in Human Microglia. The Journal of Immunology 1998;161:1989-1996. [DOI: 10.4049/jimmunol.161.4.1989] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 104 |
Stokkers PC, van Aken BE, Basoski N, Reitsma PH, Tytgat GN, van Deventer SJ. Five genetic markers in the interleukin 1 family in relation to inflammatory bowel disease. Gut 1998;43:33-9. [PMID: 9771403 DOI: 10.1136/gut.43.1.33] [Cited by in Crossref: 62] [Cited by in F6Publishing: 69] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 105 |
Saiki T, Mitsuyama K, Toyonaga A, Ishida H, Tanikawa K. Detection of pro- and anti-inflammatory cytokines in stools of patients with inflammatory bowel disease. Scand J Gastroenterol 1998;33:616-22. [PMID: 9669634 DOI: 10.1080/00365529850171891] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 106 |
Martin D, Miller G, Neuberger T, Relton J, Fischer N. Role of IL-1 in Neurodegeneration. Neuroinflammation 1998. [DOI: 10.1007/978-1-59259-473-3_7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 107 |
Krakauer T, Oppenheim JJ. Interleukin 1 and its Receptors. Encyclopedia of Immunology 1998. [DOI: 10.1006/rwei.1999.0363] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 108 |
Lorenz W, Mckneally M, Troidl H, Banerjee JK, Benbassat J, Dziri C, Fagniez P, Little JM, Wong J, Wulff HR. Surgical Research around the World. Surgical Research 1998. [DOI: 10.1007/978-1-4612-1888-3_65] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 109 |
Hacker UT, Gomolka M, Keller E, Eigler A, Folwaczny C, Fricke H, Albert E, Loeschke K, Endres S. Lack of association between an interleukin-1 receptor antagonist gene polymorphism and ulcerative colitis. Gut 1997;40:623-7. [PMID: 9203941 DOI: 10.1136/gut.40.5.623] [Cited by in Crossref: 26] [Cited by in F6Publishing: 32] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 110 |
Barclay AN, Brown MH, Law SA, Mcknight AJ, Tomlinson MG, van der Merwe PA. IL-1R. The Leucocyte Antigen FactsBook 1997. [DOI: 10.1016/b978-012078185-0/50590-4] [Reference Citation Analysis]
|
| 111 |
Hartmann G, Endres S. n-3 Polyunsaturated Fatty Acids and Human Cytokine Synthesis. Handbook of Essential Fatty Acid Biology 1997. [DOI: 10.1007/978-1-4757-2582-7_5] [Reference Citation Analysis]
|
| 112 |
Lukić ML, Ejdus L, Shahin A, Pravica V, Stošić-grujičić S, Stojković MM, Kolarević S, Liew E, Ramić Z, Badovinac V. Down-regulation of Th1 Mediated Autoimmune Pathology. Immunoregulation in Health and Disease 1997. [DOI: 10.1016/b978-012459460-9/50027-5] [Reference Citation Analysis]
|
| 113 |
Weksler N, Chorni I, Gurman GM. The Impact of Continuous Venovenous Hemofiltration in Nonoliguric Septic Patients. Anaesthesia, Pain, Intensive Care and Emergency Medicine — A.P.I.C.E. 1997. [DOI: 10.1007/978-88-470-2296-6_46] [Reference Citation Analysis]
|
| 114 |
Porreca E, Reale M, Di Febbo C, Di Gioacchino M, Barbacane RC, Castellani ML, Baccante G, Conti P, Cuccurullo F. Down-regulation of cyclooxygenase-2 (COX-2) by interleukin-1 receptor antagonist in human monocytes. Immunology 1996;89:424-9. [PMID: 8958057 DOI: 10.1046/j.1365-2567.1996.d01-753.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 115 |
Geiger R, Ellemunter H, Fink FM, Falk M, Tilg H. Circulating interleukin-1 receptor antagonist levels in neonates. Eur J Pediatr 1996;155:811-4. [PMID: 8874118 DOI: 10.1007/BF02002913] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 116 |
Loddick SA, Rothwell NJ. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. J Cereb Blood Flow Metab 1996;16:932-40. [PMID: 8784237 DOI: 10.1097/00004647-199609000-00017] [Cited by in Crossref: 370] [Cited by in F6Publishing: 378] [Article Influence: 13.7] [Reference Citation Analysis]
|
| 117 |
Distante V, Farouk M, Kurzawinski TR, Monticelli SW, Burroughs AK, Davidson BR, Rolles K. Duct-to-duct biliary reconstruction following liver transplantation for primary sclerosing cholangitis. Transplant Int 1996;9:S126-S131. [DOI: 10.1111/j.1432-2277.1996.tb01588.x] [Reference Citation Analysis]
|
| 118 |
Molina L, Studenberg S, Wolberg G, Kazmierski W, Wilson J, Tadepalli A, Chang AC, Kosanke S, Hinshaw L. Efficacy of treatment with the iron (III) complex of diethylenetriamine pentaacetic acid in mice and primates inoculated with live lethal dose 100 Escherichia coli. J Clin Invest 1996;98:192-8. [PMID: 8690793 DOI: 10.1172/JCI118766] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 119 |
Gerlach J, Jörres A, Berger A, Schön M, Smith MD, Nohr R, Neuhaus P. Systemic liberation of interleukin- 1β and interleukin-1 receptor antagonist in the perioperative phase of liver transplantation. Transplant Int 1996;9:408-414. [DOI: 10.1111/j.1432-2277.1996.tb00900.x] [Reference Citation Analysis]
|
| 120 |
Schafer M, Mousa SA, Zhang Q, Carter L, Stein C. Expression of corticotropin-releasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesia. Proc Natl Acad Sci U S A 1996;93:6096-100. [PMID: 8650225 DOI: 10.1073/pnas.93.12.6096] [Cited by in Crossref: 96] [Cited by in F6Publishing: 100] [Article Influence: 3.6] [Reference Citation Analysis]
|
| 121 |
Grzelak I, Olszewski WL, Zaleska M, Durlik M, Lagiewska B, Muszynski M, Rowinski W. Blood cytokine levels rise even after minor surgical trauma. J Clin Immunol 1996;16:159-64. [PMID: 8734359 DOI: 10.1007/BF01540914] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 122 |
Kristiansson M, Soop M, Saraste L, Sundqvist KG. Cytokines in stored red blood cell concentrates: promoters of systemic inflammation and simulators of acute transfusion reactions? Acta Anaesthesiol Scand 1996;40:496-501. [PMID: 8738697 DOI: 10.1111/j.1399-6576.1996.tb04475.x] [Cited by in Crossref: 88] [Cited by in F6Publishing: 96] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 123 |
Kadota J, Matsubara Y, Ishimatsu Y, Ashida M, Abe K, Shirai R, Iida K, Kawakami K, Taniguchi H, Fujii T, Kaseda M, Kawamoto S, Kohno S. Significance of IL-1beta and IL-1 receptor antagonist (IL-1Ra) in bronchoalveolar lavage fluid (BALF) in patients with diffuse panbronchiolitis (DPB). Clin Exp Immunol 1996;103:461-6. [PMID: 8608647 DOI: 10.1111/j.1365-2249.1996.tb08303.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 124 |
Endres S. n-3 polyunsaturated fatty acids and human cytokine synthesis. Lipids 1996;31 Suppl:S239-42. [PMID: 8729126 DOI: 10.1007/BF02637083] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 125 |
Shanley TP, Peters JL, Jones ML, Chensue SW, Kunkel SL, Ward PA. Regulatory effects of endogenous interleukin-1 receptor antagonist protein in immunoglobulin G immune complex-induced lung injury. J Clin Invest 1996;97:963-70. [PMID: 8613550 DOI: 10.1172/JCI118520] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 126 |
Tullus K, Escobar-Billing R, Fituri O, Burman LG, Karlsson A, Wikstad I, Wretlind B, Brauner A. Interleukin-1 alpha and interleukin-1 receptor antagonist in the urine of children with acute pyelonephritis and relation to renal scarring. Acta Paediatr 1996;85:158-62. [PMID: 8640042 DOI: 10.1111/j.1651-2227.1996.tb13984.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 127 |
Makarov SS, Olsen JC, Johnston WN, Anderle SK, Brown RR, Baldwin AS Jr, Haskill JS, Schwab JH. Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA. Proc Natl Acad Sci U S A 1996;93:402-6. [PMID: 8552648 DOI: 10.1073/pnas.93.1.402] [Cited by in Crossref: 147] [Cited by in F6Publishing: 161] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 128 |
Griffiths MJD, Evans TW. Prospects for Pharmacotherapy. ARDS Acute Respiratory Distress in Adults 1996. [DOI: 10.1007/978-1-4899-3430-7_30] [Reference Citation Analysis]
|
| 129 |
Talmadge JE. Immunopharmacology and Immunotherapy of Human Cancer. Immunopharmacology Reviews Volume 2 1996. [DOI: 10.1007/978-1-4613-0349-7_3] [Reference Citation Analysis]
|
| 130 |
Louis PT. Initial approach to the child who presents in presumed septic shock. Seminars in Pediatric Infectious Diseases 1995;6:223-231. [DOI: 10.1016/s1045-1870(05)80006-8] [Reference Citation Analysis]
|
| 131 |
Airaghi L, Lettino M, Manfredi MG, Lipton JM, Catania A. Endogenous cytokine antagonists during myocardial ischemia and thrombolytic therapy. Am Heart J 1995;130:204-11. [PMID: 7631597 DOI: 10.1016/0002-8703(95)90430-1] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 132 |
Kawaguchi H, Pilbeam CC, Vargas SJ, Morse EE, Lorenzo JA, Raisz LG. Ovariectomy enhances and estrogen replacement inhibits the activity of bone marrow factors that stimulate prostaglandin production in cultured mouse calvariae. J Clin Invest 1995;96:539-48. [PMID: 7615826 DOI: 10.1172/JCI118066] [Cited by in Crossref: 111] [Cited by in F6Publishing: 115] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 133 |
Engler R. Protéines de la réaction inflammatoire. Revue Française des Laboratoires 1995;1995:93-99. [DOI: 10.1016/s0338-9898(95)80365-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 134 |
Luger TA, Schwarz T. The role of cytokines and neuroendocrine hormones in cutaneous immunity and inflammation. Allergy 1995;50:292-302. [PMID: 7573811 DOI: 10.1111/j.1398-9995.1995.tb01151.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 135 |
Schetz M, Ferdinande P, Van den Berghe G, Verwaest C, Lauwers P. Removal of pro-inflammatory cytokines with renal replacement therapy: sense or nonsense? Intensive Care Med 1995;21:169-76. [PMID: 7775699 DOI: 10.1007/BF01726541] [Cited by in Crossref: 93] [Cited by in F6Publishing: 97] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 136 |
Dinarello CA. Traditional and Novel Approaches to Interleukin-1 Antagonism. Yearbook of Intensive Care and Emergency Medicine 1995. [DOI: 10.1007/978-3-642-79154-3_35] [Reference Citation Analysis]
|
| 137 |
Fürstenberger G, Müller-decker K. Networks of intercellular communication: Eicosanoids and cytokines as mediators of the response of skin to toxicity. Modulation of Cellular Responses in Toxicity 1995. [DOI: 10.1007/978-3-642-79872-6_8] [Reference Citation Analysis]
|
| 138 |
Bachert C, Hauser U, Prem B, Rudack C, Ganzer U. Proinflammatory cytokines in allergic rhinitis. Eur Arch Otorhinolaryngol 1995;252 Suppl 1:S44-9. [PMID: 7537566 DOI: 10.1007/BF02484434] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 139 |
Bachert C. Die Schleimhaut der oberen Atemwege — Zur Pathophysiologie der Entzündung. Teil I: Referate 1995. [DOI: 10.1007/978-3-642-79553-4_4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 140 |
Gross V, Andus T, Daig R, Gelbmann C, Aschenbrenner E, Vogl D, Falk W, Schölmerich J. Welche Rolle spielen Makrophagen, Mastzellen und die lokale Freisetzung von Entzündungsmediatoren in der Perpetuierung chronischer Entzündungen der Darmschleimhaut? Molekularbiologische Grundlagen der Gastroenterologie 1995. [DOI: 10.1007/978-3-642-79782-8_33] [Reference Citation Analysis]
|
| 141 |
Shiosaki K, Puttfarcken P. Chapter 4. Emerging Opportunities in Neuroinflammatory Mechanisms of Neurodegeneration. Annual Reports in Medicinal Chemistry 1995. [DOI: 10.1016/s0065-7743(08)60917-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 142 |
Thornberry NA, Molineaux SM. Interleukin-1 beta converting enzyme: a novel cysteine protease required for IL-1 beta production and implicated in programmed cell death. Protein Sci 1995;4:3-12. [PMID: 7773174 DOI: 10.1002/pro.5560040102] [Cited by in Crossref: 126] [Cited by in F6Publishing: 136] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 143 |
Schepp W. Exokrine und endokrine Funktionen des Magens. Molekularbiologische Grundlagen der Gastroenterologie 1995. [DOI: 10.1007/978-3-642-79782-8_14] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 144 |
Luger TA, Schwarz T. Cytokines and Neuroendocrine Hormones as Mediators of Cutaneous Immunity and Inflammation. Symposium in Immunology IV 1995. [DOI: 10.1007/978-3-642-79446-9_1] [Reference Citation Analysis]
|
| 145 |
Chatenoud L, Webb M, Bach J. Future Goals for Therapeutic Monoclonal Antibodies. Monoclonal Antibodies in Transplantation 1995. [DOI: 10.1007/978-3-662-22195-2_6] [Reference Citation Analysis]
|
| 146 |
Kitazawa R, Kimble RB, Vannice JL, Kung VT, Pacifici R. Interleukin-1 receptor antagonist and tumor necrosis factor binding protein decrease osteoclast formation and bone resorption in ovariectomized mice. J Clin Invest 1994;94:2397-406. [PMID: 7989596 DOI: 10.1172/JCI117606] [Cited by in Crossref: 251] [Cited by in F6Publishing: 266] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 147 |
Sekiyama KD, Yoshiba M, Thomson AW. Circulating proinflammatory cytokines (IL-1 beta, TNF-alpha, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis. Clin Exp Immunol 1994;98:71-7. [PMID: 7923888 DOI: 10.1111/j.1365-2249.1994.tb06609.x] [Cited by in Crossref: 121] [Cited by in F6Publishing: 132] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 148 |
Ferretti M, Casini-Raggi V, Pizarro TT, Eisenberg SP, Nast CC, Cominelli F. Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis. J Clin Invest 1994;94:449-53. [PMID: 8040288 DOI: 10.1172/JCI117345] [Cited by in Crossref: 113] [Cited by in F6Publishing: 126] [Article Influence: 3.9] [Reference Citation Analysis]
|
| 149 |
Sütö G, Király A, Taché Y. Interleukin 1 beta inhibits gastric emptying in rats: mediation through prostaglandin and corticotropin-releasing factor. Gastroenterology 1994;106:1568-75. [PMID: 8194703 DOI: 10.1016/0016-5085(94)90412-x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 66] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 150 |
Theodorou V, Fioramonti J, Junien JL, Bueno L. Anaphylactic colonic hypersecretion in cow's milk sensitized guinea-pigs depends upon release of interleukin-1, prostaglandins and mast cell degranulation. Aliment Pharmacol Ther 1994;8:301-7. [PMID: 7918925 DOI: 10.1111/j.1365-2036.1994.tb00292.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 151 |
Schäfer M, Carter L, Stein C. Interleukin 1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue. Proc Natl Acad Sci U S A 1994;91:4219-23. [PMID: 7910403 DOI: 10.1073/pnas.91.10.4219] [Cited by in Crossref: 210] [Cited by in F6Publishing: 217] [Article Influence: 7.2] [Reference Citation Analysis]
|
| 152 |
Yanni G, Nabil M, Farahat MR, Poston RN, Panayi GS. Intramuscular gold decreases cytokine expression and macrophage numbers in the rheumatoid synovial membrane. Ann Rheum Dis 1994;53:315-22. [PMID: 8017985 DOI: 10.1136/ard.53.5.315] [Cited by in Crossref: 70] [Cited by in F6Publishing: 81] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 153 |
Kimble RB, Vannice JL, Bloedow DC, Thompson RC, Hopfer W, Kung VT, Brownfield C, Pacifici R. Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats. J Clin Invest 1994;93:1959-67. [PMID: 8182127 DOI: 10.1172/JCI117187] [Cited by in Crossref: 185] [Cited by in F6Publishing: 193] [Article Influence: 6.4] [Reference Citation Analysis]
|
| 154 |
Poli G, Kinter AL, Fauci AS. Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist. Proc Natl Acad Sci U S A 1994;91:108-12. [PMID: 7506410 DOI: 10.1073/pnas.91.1.108] [Cited by in Crossref: 142] [Cited by in F6Publishing: 147] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 155 |
Opal SM, Fisher CJ, Pribble J. The Treatment of Sepsis with Interleukin-1 Receptor Antagonist. Update in Intensive Care and Emergency Medicine 1994. [DOI: 10.1007/978-3-642-85036-3_30] [Reference Citation Analysis]
|
| 156 |
Highton J, Palmer DG. The Mononuclear Phagocyte and Rheumatoid Arthritis. Immunology of the Connective Tissue Diseases 1994. [DOI: 10.1007/978-94-011-1432-5_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 157 |
Gräfe M, Steinheider G, Graf K, Bossaller C, Auch-schwelk W, Hildebrandt A, Fleck E. Comparative Analysis of the Inductive Activity of Interleukin-1αVersusTumor Necrosis Factor α on G-CSF and GM-CSF Production by Human Vascular Endothelial Cells. Endothelium 1994;1:245-250. [DOI: 10.3109/10623329409100962] [Reference Citation Analysis]
|
| 158 |
Saperas E, Taché Y. Interleukin-1 receptor antagonist does not prevent endotoxin-induced inhibition of gastric acid secretion in rats. Dig Dis Sci 1994;39:152-6. [PMID: 8281850 DOI: 10.1007/BF02090075] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 159 |
Luger T. Zytokine und ihre Bedeutung für Wundheilungsprozesse. Wundheilung — Wundverschluß 1994. [DOI: 10.1007/978-3-642-79173-4_2] [Reference Citation Analysis]
|
| 160 |
Delves P. CELL-SURFACE ANTIGENS. Cellular Immunology 1994. [DOI: 10.1016/b978-0-12-208885-8.50013-2] [Reference Citation Analysis]
|
| 161 |
Boraschi D, Tagliabue A. Engineering of IL-1 Antagonists. Medical Science Symposia Series 1994. [DOI: 10.1007/978-94-011-1108-9_18] [Reference Citation Analysis]
|
| 162 |
Wilson AG, Duff GW. Cytokines and Inflammatory Arthritis. Immunology of the Connective Tissue Diseases 1994. [DOI: 10.1007/978-94-011-1432-5_5] [Reference Citation Analysis]
|
| 163 |
Bandara G, Mueller GM, Galea-Lauri J, Tindal MH, Georgescu HI, Suchanek MK, Hung GL, Glorioso JC, Robbins PD, Evans CH. Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer. Proc Natl Acad Sci U S A 1993;90:10764-8. [PMID: 8248169 DOI: 10.1073/pnas.90.22.10764] [Cited by in Crossref: 213] [Cited by in F6Publishing: 233] [Article Influence: 7.1] [Reference Citation Analysis]
|
| 164 |
Tilg H, Vannier E, Vachino G, Dinarello CA, Mier JW. Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells. J Exp Med 1993;178:1629-36. [PMID: 7693853 DOI: 10.1084/jem.178.5.1629] [Cited by in Crossref: 186] [Cited by in F6Publishing: 198] [Article Influence: 6.2] [Reference Citation Analysis]
|
| 165 |
Strassmann G, Fong M, Freter CE, Windsor S, D'Alessandro F, Nordan RP. Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivo. J Clin Invest 1993;92:2152-9. [PMID: 8227330 DOI: 10.1172/JCI116816] [Cited by in Crossref: 98] [Cited by in F6Publishing: 103] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 166 |
Laurent GJ, Coker RK, McAnulty RJ. TGF-beta antibodies: a novel treatment for pulmonary fibrosis? Thorax 1993;48:953-4. [PMID: 8256239 DOI: 10.1136/thx.48.10.953] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 167 |
Piguet PF, Vesin C, Ryser JE, Senaldi G, Grau GE, Tacchini-Cottier F. An effector role for platelets in systemic and local lipopolysaccharide-induced toxicity in mice, mediated by a CD11a- and CD54-dependent interaction with endothelium. Infect Immun 1993;61:4182-7. [PMID: 8104895 DOI: 10.1128/iai.61.10.4182-4187.1993] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 168 |
Takao T, Newton RC, De Souza EB. Species differences in [125I]interleukin-1 binding in brain, endocrine and immune tissues. Brain Res 1993;623:172-6. [PMID: 8221088 DOI: 10.1016/0006-8993(93)90026-j] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 169 |
Zumsteg U, Reimers JI, Pociot F, Mørch L, Helqvist S, Brendel M, Alejandro R, Mandrup-Poulsen T, Dinarello CA, Nerup J. Differential interleukin-1 receptor antagonism on pancreatic beta and alpha cells. Studies in rodent and human islets and in normal rats. Diabetologia 1993;36:759-66. [PMID: 8405744 DOI: 10.1007/BF00401148] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 170 |
Agosti JM. AUTOIMMUNITY IN INFECTIOUS DISEASES. Immunology and Allergy Clinics of North America 1993;13:459-486. [DOI: 10.1016/s0889-8561(22)00170-9] [Reference Citation Analysis]
|
| 171 |
Tarlow JK, Blakemore AI, Lennard A, Solari R, Hughes HN, Steinkasserer A, Duff GW. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993;91:403-4. [PMID: 8500797 DOI: 10.1007/BF00217368] [Cited by in Crossref: 451] [Cited by in F6Publishing: 486] [Article Influence: 15.0] [Reference Citation Analysis]
|
| 172 |
Patent Evaluation: Novel peptidic interleukin-1p converting enzyme inhibitors. Current Opinion on Therapeutic Patents 1993;3:613-615. [DOI: 10.1517/13543776.3.5.613] [Reference Citation Analysis]
|
| 173 |
Youngman KR, Simon PL, West GA, Cominelli F, Rachmilewitz D, Klein JS, Fiocchi C. Localization of intestinal interleukin 1 activity and protein and gene expression to lamina propria cells. Gastroenterology 1993;104:749-58. [PMID: 8440434 DOI: 10.1016/0016-5085(93)91010-f] [Cited by in Crossref: 142] [Cited by in F6Publishing: 148] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 174 |
Mancilla J, García P, Dinarello CA. The interleukin-1 receptor antagonist can either reduce or enhance the lethality of Klebsiella pneumoniae sepsis in newborn rats. Infect Immun 1993;61:926-32. [PMID: 8432613 DOI: 10.1128/iai.61.3.926-932.1993] [Cited by in Crossref: 45] [Cited by in F6Publishing: 51] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 175 |
Martel-Pelletier J, McCollum R, Pelletier JP. The synthesis of IL-1 receptor antagonist (IL-1ra) by synovial fibroblasts is markedly increased by the cytokines TNF-alpha and IL-1. Biochim Biophys Acta 1993;1175:302-5. [PMID: 8435447 DOI: 10.1016/0167-4889(93)90221-a] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 176 |
Taché Y, Saperas E. Central Actions of Interleukin 1 on Gastrointestinal Function. Methods in Neurosciences 1993. [DOI: 10.1016/s1043-9471(13)70015-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 177 |
van der Meer JWM, Vogels M, Curfs JHAJ, Kuliberg B, Eling WMC. Interleukin-1 and its Receptor Antagonist as Candidate Therapeutic Agents for Severe Infections. Shock, Sepsis, and Organ Failure 1993. [DOI: 10.1007/978-3-642-77420-1_14] [Reference Citation Analysis]
|
| 178 |
Opal SM. IL-1ra as a Therapeutic Modality in Sepsis. Yearbook of Intensive Care and Emergency Medicine 1993 1993. [DOI: 10.1007/978-3-642-84904-6_10] [Reference Citation Analysis]
|
| 179 |
Takao T, Grigoriadis DE, De Souza EB. Identification, Autoradiographic Localization, and Modulation of Interleukin 1 Receptors in Brain–Endocrine–Immune Axis: Methodology and Overview. Methods in Neurosciences 1993. [DOI: 10.1016/b978-0-12-185281-8.50014-4] [Reference Citation Analysis]
|
| 180 |
Brynskov J, Nielsen OH, Ahnfelt-Rønne I, Bendtzen K. Cytokines in inflammatory bowel disease. Scand J Gastroenterol 1992;27:897-906. [PMID: 1455185 DOI: 10.3109/00365529209000160] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 181 |
Young RR, Segal JL. Guest Editorial. The Journal of The American Paraplegia Society 1992;15:209-210. [DOI: 10.1080/01952307.1992.11761519] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
| 182 |
Kenefick KB, Lederer JA, Schell RF, Czuprynski CJ. Borrelia burgdorferi stimulates release of interleukin-1 activity from bovine peripheral blood monocytes. Infect Immun 1992;60:3630-4. [PMID: 1500171 DOI: 10.1128/iai.60.9.3630-3634.1992] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 183 |
Miller LC, Isa S, Vannier E, Georgilis K, Steere AC, Dinarello CA. Live Borrelia burgdorferi preferentially activate interleukin-1 beta gene expression and protein synthesis over the interleukin-1 receptor antagonist. J Clin Invest 1992;90:906-12. [PMID: 1387885 DOI: 10.1172/JCI115966] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 184 |
Zamir O, Hasselgren PO, O'Brien W, Thompson RC, Fischer JE. Muscle protein breakdown during endotoxemia in rats and after treatment with interleukin-1 receptor antagonist (IL-1ra). Ann Surg 1992;216:381-5; discussion 386-7. [PMID: 1417187 DOI: 10.1097/00000658-199209000-00018] [Cited by in Crossref: 37] [Cited by in F6Publishing: 45] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 185 |
Piguet PF. Keratinocyte-derived tumor necrosis factor and the physiopathology of the skin. Springer Semin Immunopathol 1992;13:345-54. [PMID: 1411901 DOI: 10.1007/BF00200533] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 186 |
Dinarello CA. Role of interleukin-1 in infectious diseases. Immunol Rev 1992;127:119-46. [PMID: 1506003 DOI: 10.1111/j.1600-065x.1992.tb01411.x] [Cited by in Crossref: 141] [Cited by in F6Publishing: 144] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 187 |
Vannier E, Miller LC, Dinarello CA. Coordinated antiinflammatory effects of interleukin 4: interleukin 4 suppresses interleukin 1 production but up-regulates gene expression and synthesis of interleukin 1 receptor antagonist. Proc Natl Acad Sci U S A 1992;89:4076-80. [PMID: 1533284 DOI: 10.1073/pnas.89.9.4076] [Cited by in Crossref: 207] [Cited by in F6Publishing: 219] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 188 |
Cerretti DP, Kozlosky CJ, Mosley B, Nelson N, Van Ness K, Greenstreet TA, March CJ, Kronheim SR, Druck T, Cannizzaro LA. Molecular cloning of the interleukin-1 beta converting enzyme. Science 1992;256:97-100. [PMID: 1373520 DOI: 10.1126/science.1373520] [Cited by in Crossref: 824] [Cited by in F6Publishing: 870] [Article Influence: 26.6] [Reference Citation Analysis]
|
| 189 |
Beutler B. Cytokines in Shock: 1992. Update in Intensive Care and Emergency Medicine 1992. [DOI: 10.1007/978-3-642-84827-8_4] [Reference Citation Analysis]
|
| 190 |
Dinarello CA. Blocking Cytokines in Infectious Diseases. Update in Intensive Care and Emergency Medicine 1992. [DOI: 10.1007/978-3-642-84827-8_26] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
|
